HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes

Get up to date on the latest guideline recommendations and clinical data regarding testing and treatment strategies for HER2-positive gastric and colorectal cancers with downloadable slides from a live CME-certified satellite symposium at ASCO 2023, an on-demand webcast, and expert commentary on frequently asked questions.

Share

Program Content

Activities

HER2 Testing in GI Cancers
Incorporating Guideline-Recommended HER2 Testing Into GI Cancer Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2023

HER2 Therapy in Gastric Cancer
HER2 Precision Therapy in Advanced Gastric/GEJ Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2023

HER2 Therapy in CRC
The Emerging Role of HER2 as a Target in Advanced CRC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2023

Activities

HER2-Positive Advanced GI Cancers
HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2023

Expires: June 20, 2024

Activities

FAQs: HER2-Positive GI Cancers
Targeted Therapies for HER2-Positive Gastrointestinal Cancers: Experts Answer Your Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 12, 2023

Faculty

cover img faculity

Geoffrey Ku, MD

Associate Attending Physician
Head, Esophagogastric Section, Gastrointestinal Oncology Service & member, Cellular Therapy Service
Department of Medicine

cover img faculity

Kanwal Raghav, MD

Associate Professor
Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Zev A. Wainberg, MD

Professor of Medicine and Surgery
Co-Director, GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Seagen Inc.